Glazer Capital LLC’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

Glazer Capital LLC’s Portfolio RARX Stock Details RARX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-67,754	Closed	-$3.25M	–	246
2020 Q1	$3.25M	Buy	+67,754	New	+$3.15M	0.22%	85

Other funds holding RARX

Daiwa Securities Group Tokyo, Japan $34.8B AUM 20.7% 1-Year Est. Return

Glazer Capital LLC's RARX Position: Q2 2020 in Review

Glazer Capital LLC sold out of Ra Pharmaceuticals, Inc. Common Stock (RARX) in Q2 2020, closing a stake of 67,754 shares — an estimated $3.25M sold.

Glazer Capital LLC first reported a position in RARX in Q1 2020 and held it in 1 quarter. The position peaked at $3.25M in Q1 2020. 1 fund tracked by Wall St. Rank holds RARX as of Q2 2020.

Glazer Capital LLC reported no remaining Ra Pharmaceuticals, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
Glazer Capital LLC sold 67,754 Ra Pharmaceuticals, Inc. Common Stock shares in Q2 2020, an estimated $3.25M.
Glazer Capital LLC first reported a position in Ra Pharmaceuticals, Inc. Common Stock in Q1 2020 and held it in 1 quarter.
Glazer Capital LLC's Ra Pharmaceuticals, Inc. Common Stock position peaked at $3.25M in Q1 2020.
1 fund tracked by Wall St. Rank held Ra Pharmaceuticals, Inc. Common Stock as of Q2 2020.

Based on Glazer Capital LLC's 13F filing for Q2 2020, filed 14 Aug 2020.